Answers are grounded in this paper and cite their sources.
TET2, located on chromosome 4q24, is frequently mutated (~60%) in patients with chronic myelomonocytic leukemia (CMML). 1,2 TET2 has 11 exons, and variations, especially in exon 3 have been described as a part of age-related clonal hematopoiesis. and all-cause mortality (HR-3.7). The exact mechanism behind this interaction remains to be elucidated, one potential explanation being better responses to hypomethylating agents. In the current larger CMML patient cohort (n = 261), we describe the number and type of TET2 mutations and examine their phenotypic and prognostic effects.
No takes yet. Share an insight, caveat, or question.
Patnaik et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: